Status:
COMPLETED
Effectiveness of Medical Management of Fibrous Dysplasia of Bone.
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Fibrous Dysplasia of Bone
McCune Albright Syndrome
Eligibility:
All Genders
Brief Summary
The objective of our study was to assess the effectiveness of our reference center since its constitution. In a retrospective cohort study, we compared the activity of our center, including the time ...
Eligibility Criteria
Inclusion
- We have included children and adults with FD/MAS who visited at least once in our center (outpatient and hospitalized patients). The diagnosis was established by an expert of the center, based on clinical, biological, imaging and/or histological arguments
Exclusion
- The absence of detectable bone lesion
Key Trial Info
Start Date :
January 1 1996
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
528 Patients enrolled
Trial Details
Trial ID
NCT05422833
Start Date
January 1 1996
End Date
December 1 2019
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
rheumatology department, hopital Edouard Herriot
Lyon, France, 69003